Pfizer (PFE) pays $0.43 dividend with an 8.76% yield — 26 years running

Pfizer's quarterly dividend of $0.43 per share translates to a trailing annual payout of $2.15, putting its yield at 8.76% — a level that meaningfully exceeds what most investment-grade bonds are currently offering income-focused investors. That gap makes PFE a notable income option in a market where yield is still a central concern for portfolios.

The ex-dividend date for this payment is July 24, 2026, meaning investors need to hold shares before that date to qualify for the payout. The dividend is unchanged from a year ago, reflecting a period of stability rather than growth in the payout itself — a signal that Pfizer is prioritizing consistency over expansion of its dividend at this point in time.

The 26-year streak of unbroken payments is the backdrop that gives this yield its weight. Sustaining dividends across more than two decades means the company has continued paying through multiple economic downturns, patent cliffs, and industry upheavals — a track record that income investors often treat as a key measure of reliability.